Solution structure of polyglutamine tracts in GST‐polyglutamine fusion proteins

Aggregation of expanded polyglutamine (polyQ) seems to be the cause of various genetic neurodegenerative diseases. Relatively little is known as yet about the polyQ structure and the mechanism that induces aggregation. We have characterised the solution structure of polyQ in a proteic context using a model system based on glutathione S‐transferase fusion proteins. A wide range of biophysical techniques was applied. For the first time, nuclear magnetic resonance was used to observe directly and selectively the conformation of polyQ in the pathological range. We demonstrate that, in solution, polyQs are in a random coil conformation. However, under destabilising conditions, their aggregation behaviour is determined by the polyQ length.

[1]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[2]  E. Wanker Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations , 2000, Biological chemistry.

[3]  P. V. van Zijl,et al.  Accurate Quantitation of Water-amide Proton Exchange Rates Using the Phase-Modulated CLEAN Chemical EXchange (CLEANEX-PM) Approach with a Fast-HSQC (FHSQC) Detection Scheme , 1998, Journal of biomolecular NMR.

[4]  E. Grishin,et al.  Three-dimensional structure of ectatomin from Ectatomma tuberculatum ant venom , 1995, Journal of biomolecular NMR.

[5]  A. Bax,et al.  Measurement of the exchange rates of rapidly exchanging amide protons: Application to the study of calmodulin and its complex with a myosin light chain kinase fragment , 1991, Journal of biomolecular NMR.

[6]  J L Sussman,et al.  Protein Data Bank archives of three-dimensional macromolecular structures. , 1997, Methods in enzymology.

[7]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[8]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[9]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Lehrach,et al.  Huntingtin aggregation monitored by dynamic light scattering. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G P Bates,et al.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J T Yang,et al.  Calculation of protein conformation from circular dichroism. , 1986, Methods in enzymology.

[13]  D. Wishart,et al.  The 13C Chemical-Shift Index: A simple method for the identification of protein secondary structure using 13C chemical-shift data , 1994, Journal of biomolecular NMR.

[14]  Yves Agid,et al.  Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats , 1996, Nature Genetics.

[15]  James F. Gusella,et al.  Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.

[16]  M. Perutz,et al.  Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Albin,et al.  Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse , 1997, Cell.

[18]  K Wüthrich,et al.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules , 1995, Journal of biomolecular NMR.

[19]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[20]  H. Lehrach,et al.  Aggregation of truncated GST-HD exon 1 fusion proteins containing normal range and expanded glutamine repeats. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  L. Kay,et al.  Pulse sequences for removal of the effects of cross correlation between dipolar and chemical-shift anisotropy relaxation mechanisms on the measurement of heteronuclear T1 and T2 values in proteins , 1992 .

[22]  G. Lipari Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules , 1982 .

[23]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[24]  N. Sreerama,et al.  Estimation of protein secondary structure from circular dichroism spectra: inclusion of denatured proteins with native proteins in the analysis. , 2000, Analytical biochemistry.

[25]  J. Vance,et al.  Toxicity of expanded polyglutamine‐domain proteins in Escherichia coli , 1996, FEBS letters.

[26]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[27]  M W Parker,et al.  Evidence for an induced-fit mechanism operating in pi class glutathione transferases. , 1998, Biochemistry.

[28]  S. Brahmachari,et al.  Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions , 1999, FEBS letters.

[29]  F. Richards,et al.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.

[30]  C. Jodice,et al.  Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro , 2001, Brain Research Bulletin.

[31]  Charles S. Johnson,et al.  A PFG NMR experiment for accurate diffusion and flow studies in the presence of eddy currents , 1991 .

[32]  Max F. Perutz,et al.  Glutamine repeats and neurodegenerative diseases: molecular aspects. , 1999, Trends in biochemical sciences.

[33]  E. Altschuler,et al.  Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[34]  D. Neuhaus,et al.  Solution studies of chymotrypsin inhibitor-2 glutamine insertion mutants show no interglutamine interactions. , 2001, Biochemical and biophysical research communications.